Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
235 hedge funds and large institutions have $2.59B invested in Axonics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 93 increasing their positions, 84 reducing their positions, and 36 closing their positions.
11% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 84
0% less funds holding
Funds holding: 236 → 235 (-1)
3% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 36
8% less capital invested
Capital invested by funds: $2.83B → $2.59B (-$238M)
27% less call options, than puts
Call options by funds: $1.01M | Put options by funds: $1.38M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
B
Braidwell
Stamford,
Connecticut
|
+$21.7M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$21.5M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$20.3M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$20.2M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$16.6M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$53.9M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$46.3M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$27.6M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$16.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$14.4M |
AXNX Hedge Fund Activity: Q2 2023 in Review
235 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q2 2023, worth a combined $2.59B — down 8.4% from $2.83B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of AXNX and 35 opened new positions — a net loss of 1 holder — while 84 trimmed existing stakes and 93 added.
The largest buyer was Braidwell, adding an estimated $21.7M. The largest seller was Point72 Asset Management, cutting an estimated $53.9M.
- 235 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q2 2023, down from 236 in Q1 2023.
- Funds reported $2.59B of Axonics, Inc. Common Stock stock for Q2 2023, down 8.4% quarter-over-quarter.
- 35 funds opened new Axonics, Inc. Common Stock positions in Q2 2023 and 36 closed out, a net change of -1 holder.
- The largest Axonics, Inc. Common Stock buyer in Q2 2023 was Braidwell, an estimated $21.7M added.
- The largest Axonics, Inc. Common Stock seller in Q2 2023 was Point72 Asset Management, an estimated $53.9M sold.
Based on aggregated 13F filings for Q2 2023.